Exodus Point Capital Management, LP Nurix Therapeutics, Inc. Transaction History
Exodus Point Capital Management, LP
- $14.7 Billion
- Q2 2024
A detailed history of Exodus Point Capital Management, LP transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 320,552 shares of NRIX stock, worth $6.95 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
320,552
Previous 165,603
93.57%
Holding current value
$6.95 Million
Previous $2.43 Million
174.86%
% of portfolio
0.05%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding NRIX
# of Institutions
183Shares Held
66.3MCall Options Held
40.9KPut Options Held
106K-
Black Rock Inc. New York, NY6.82MShares$148 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.42MShares$95.9 Million6.02% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.99MShares$86.5 Million2.73% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$84.1 Million1.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$78.6 Million0.0% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $1.02B
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...